내시경 장비 시장 : 제품 카테고리, 검사 목적, 사용성, 시스템 구성, 임상 적응, 최종 사용자, 환자 연령층별 - 세계 시장 예측(2026-2032년)

The Endoscopy Equipment Market is projected to grow by USD 60.16 billion at a CAGR of 7.65% by 2032.

Endoscopy Equipment Market Executive Summary

Endoscopy equipment is central to minimally invasive diagnosis and therapy across gastroenterology, pulmonology, urology, gynecology, ENT, and surgical specialties. Demand is supported by the documented burden of cancer, gastrointestinal disease, obesity-related disorders, and age-associated chronic conditions, with the United Nations projecting the global population aged 65 and older to more than double by 2050.

The industry is moving beyond conventional scopes toward high-definition visualization, single-use endoscopes, capsule endoscopy, endoscopic ultrasound, therapeutic accessories, automated reprocessing systems, and AI-assisted detection. For healthcare providers, the strategic priority is clear: improve diagnostic yield, reduce procedure-related risk, and expand procedure capacity without compromising infection prevention or regulatory compliance.

Transformative Shifts in Endoscopy Equipment

The endoscopy equipment landscape is being reshaped by earlier cancer screening, outpatient migration, stricter infection-control expectations, and the shift from diagnostic procedures to advanced endoscopic therapy. The U.S. Preventive Services Task Force recommends colorectal cancer screening from age 45 to 75, reinforcing sustained procedural demand in mature markets and increasing interest in high-throughput endoscopy suites.

Technology adoption is also changing purchasing behavior. Hospitals and ambulatory surgery centers are prioritizing 4K and 3D visualization, narrow-band and image-enhanced imaging, disposable components, ergonomic scope design, and connected platforms that support documentation, quality metrics, and lifecycle service models. These shifts are increasing the importance of interoperability, cybersecurity, validated cleaning protocols, and staff training in endoscopy system selection.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a measurable performance enhancer in endoscopy, particularly in computer-aided detection for colonoscopy. The FDA authorized GI Genius in 2021 as the first AI-based device to assist clinicians in detecting colon lesions in real time, validating a regulated pathway for AI-assisted endoscopic workflows.

The cumulative impact of AI extends beyond lesion detection. AI can support procedure documentation, image triage, quality benchmarking, withdrawal-time analytics, training feedback, and operational scheduling. However, clinical adoption depends on validated datasets, workflow integration, cybersecurity, explainability, and physician oversight, as AI tools augment rather than replace clinical judgment.

Key Regional Insights for Endoscopy Equipment

Asia-Pacific is a major growth engine due to large patient populations, expanding hospital infrastructure, and rising investments in cancer screening and minimally invasive care, with China, India, Japan, South Korea, and Australia driving differentiated demand across public and private healthcare systems. North America remains a high-value region, supported by reimbursement structures, strong colorectal cancer screening adherence, ambulatory procedure capacity, and rapid adoption of AI-enabled, high-definition, and single-use endoscopy technologies.

Europe benefits from organized screening programs, established clinical guidelines, and strong medical device quality standards under the EU MDR framework, while Latin America is advancing through private hospital expansion and broader access to gastrointestinal and surgical endoscopy in countries such as Brazil and Mexico. The Middle East is investing in specialist hospitals, digital health infrastructure, and medical tourism, particularly in GCC countries, while Africa shows long-term opportunity as diagnostic capacity, workforce training, maintenance capability, and reprocessing infrastructure improve.

Key Group Insights Across Global Health Systems

ASEAN markets are expanding as Indonesia, Thailand, Vietnam, Malaysia, the Philippines, and Singapore increase specialty-care access, private-sector endoscopy capacity, and investment in hospital modernization. The GCC is advancing premium hospital infrastructure, digital operating room adoption, and specialized digestive disease services, while the European Union benefits from harmonized medical device regulation, public screening programs, and strong procurement standards that emphasize safety, documentation, and lifecycle performance.

BRICS economies represent scale-led opportunity, with China, India, and Brazil expanding procedure access and Russia and South Africa sustaining demand through tertiary-care networks and public-sector modernization. G7 countries lead in clinical guideline adoption, AI validation, premium imaging platforms, and quality-measure reporting. NATO countries add relevance through healthcare resilience, cybersecurity expectations, supply chain continuity, and standardized procurement practices across many high-income health systems.

Key Country Insights for Endoscopy Equipment

The United States leads in procedure volume, AI commercialization, ambulatory endoscopy center adoption, and colorectal cancer screening activity, while Canada emphasizes quality-controlled public access, provincial screening programs, and standardized clinical pathways. Mexico and Brazil are expanding private hospital networks and specialty gastroenterology services, creating demand for durable, serviceable endoscopy equipment, flexible financing, and reliable reprocessing solutions.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from established screening policies, aging populations, advanced hospital procurement, and strong clinical governance, while Russia relies on regional modernization and tertiary-care demand. China and India are scaling access rapidly through hospital expansion and rising specialist capacity, Japan and South Korea lead in advanced visualization, early cancer detection, and high procedural standards, and Australia combines strong screening participation, regulatory oversight, and demand for efficient endoscopy workflows.

Actionable Recommendations for Industry Leaders

Industry vendors should prioritize evidence-based product differentiation, including improved adenoma detection support, reduced cross-contamination risk, ergonomic design, faster turnover, and seamless integration with endoscopy reporting systems. Vendors should align product portfolios with both premium hospital requirements and cost-sensitive emerging-market needs, while ensuring compatibility with local infrastructure, service capabilities, and clinical training levels.

Strategic actions include investing in AI validation studies, building local service networks, offering flexible procurement models, training clinical users, and supporting regulatory readiness under FDA, EU MDR, and country-specific medical device rules. Providers should evaluate total cost of ownership, reprocessing capacity, cybersecurity, interoperability, uptime support, and staff training before platform selection.

Research Methodology and Data Integrity

This executive summary is based on secondary research from authoritative public sources, including regulatory agencies, public health organizations, clinical guideline bodies, peer-reviewed literature, and industry disclosures. Key reference points include WHO and GLOBOCAN cancer statistics, United Nations demographic data, USPSTF screening recommendations, FDA medical device authorizations and safety communications, EU MDR requirements, and recognized endoscopy society guidance.

The analysis triangulates disease burden, demographic trends, technology adoption, regional healthcare investment, reimbursement environment, regulatory developments, infection-control expectations, and clinical workflow requirements. Insights are structured to support endoscopy equipment, endoscopes, endoscopy systems, AI-assisted endoscopy, infection prevention, and minimally invasive diagnostic and therapeutic procedures.

Conclusion: Outlook for Endoscopy Equipment

The endoscopy equipment market is positioned for sustained relevance as healthcare systems prioritize earlier diagnosis, minimally invasive therapy, infection prevention, and procedure efficiency. Demand is supported by aging populations, cancer screening needs, chronic gastrointestinal disease, and the shift toward outpatient and digitally enabled care.

Competitive advantage will increasingly depend on clinically validated innovation, robust service coverage, regulatory compliance, infection-control performance, and AI-enabled workflow value. Organizations that combine advanced visualization, responsible AI, scalable training, and lifecycle support will be best placed to strengthen clinical impact and long-term adoption.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Endoscopy Equipment Market, by Product Category

• 7.1. Visualization Systems
  • 7.1.1. Cameras
  • 7.1.2. Video Processors
  • 7.1.3. Monitors
• 7.2. Endoscopes
  • 7.2.1. Flexible
  • 7.2.2. Rigid
• 7.3. Light Sources
• 7.4. Insufflation Systems
• 7.5. Irrigation Pumps
• 7.6. Endoscopic Accessories

8. Endoscopy Equipment Market, by Procedure Intent

• 8.1. Diagnostic
  • 8.1.1. Screening
  • 8.1.2. Surveillance
• 8.2. Therapeutic
  • 8.2.1. Resection
  • 8.2.2. Hemostasis
  • 8.2.3. Dilation
  • 8.2.4. Stenting

9. Endoscopy Equipment Market, by Usability

• 9.1. Reusable
• 9.2. Single-Use

10. Endoscopy Equipment Market, by System Configuration

• 10.1. Standalone
• 10.2. Portable

11. Endoscopy Equipment Market, by Clinical Indication

• 11.1. Gastroenterology
• 11.2. Urology
• 11.3. Gynecology
• 11.4. Orthopedics

12. Endoscopy Equipment Market, by End User

• 12.1. Hospitals
• 12.2. Ambulatory Surgery Centers
• 12.3. Specialty Clinics
• 12.4. Diagnostic Centers
• 12.5. Academic And Research Institutes

13. Endoscopy Equipment Market, by Patient Age Group

• 13.1. Pediatric
• 13.2. Adult
• 13.3. Geriatric

14. Endoscopy Equipment Market, by Region

• 14.1. Asia-Pacific
• 14.2. North America
• 14.3. Latin America
• 14.4. Europe
• 14.5. Middle East
• 14.6. Africa

15. Endoscopy Equipment Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Endoscopy Equipment Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. Ackermann Instrumente GmbH
• 18.2. Advanced Sterilization Products, Inc.
• 18.3. Ambu A/S
• 18.4. AnX Robotica Corporation
• 18.5. Aohua Endoscopy Co., Ltd.
• 18.6. Arthrex, Inc.
• 18.7. B. Braun SE
• 18.8. Becton, Dickinson and Company
• 18.9. Boston Scientific Corporation
• 18.10. CapsoVision, Inc.
• 18.11. CONMED Corporation
• 18.12. Cook Medical LLC
• 18.13. Creo Medical Group plc
• 18.14. EndoMed Systems GmbH
• 18.15. Erbe Elektromedizin GmbH
• 18.16. FUJIFILM Holdings Corporation
• 18.17. Guangdong OptoMedic Technologies, Inc.
• 18.18. HOYA Corporation
• 18.19. IntroMedic Co., Ltd.
• 18.20. Intuitive Surgical, Inc.
• 18.21. Johnson & Johnson Services Inc.
• 18.22. Karl Storz SE & Co. KG
• 18.23. Lumendi, LLC
• 18.24. Mauna Kea Technologies SA
• 18.25. Medtronic plc
• 18.26. Miele & Cie. KG
• 18.27. Olympus Corporation
• 18.28. Optomic Espana S.A.
• 18.29. Richard Wolf GmbH
• 18.30. SCHOLLY Fiberoptic GmbH
• 18.31. Smith & Nephew plc
• 18.32. Soluscope SAS
• 18.33. Steelco S.p.A.
• 18.34. STERIS plc
• 18.35. Stryker Corporation
• 18.36. Vimex Endoscopy Sp. z o.o.
• 18.37. Wassenburg Medical B.V.
• 18.38. XION GmbH